With a reported 60 percent of U.S. adults struggling with low back pain during their lifetime, Beaumont Health in Royal Oak today announced it has started research on the ReActiv8 implantable stimulation system, a new approach to pain management.
The ReActiv8 Clinical Study is evaluating the safety and effectiveness of the device for treating adults with chronic low back pain and no prior spine surgery, though it may be used in conjunction with medication.
ReActiv8 is a surgically-implanted device that delivers mild electrical stimulation to nerves in key lower back muscles, but unlike other nerve treatments, it helps patients regain control of back muscles rather than masking pain. To qualify for the study, patients must be between the ages of 22-75, have experienced lower back pain for at least three months, and have not had success with other treatment methods including medication and physical therapy.
“Beaumont currently offers innovative procedures to treat low back pain, but we think it’s important to bring new clinical trials to our patients, too,” says Dr. Jeff Fischgrund, Beaumont’ chair of orthopedics. “Stabilizing muscles can reduce back pain. While physical therapy and medications work for most, there’s a significant patient population who continue to struggle with chronic low back pain.
“We are looking for patients who have tried everything else, but still have not found relief. We are looking for patients who are not willing to settle with chronic back pain.”
Low back pain commonly starts as a simple strain or sprain in one of the spine joints. To avoid pain, the brain tries to limit muscle activity around the joints, but less activity can worsen the stability of the lower back and can lead to additional problems.
More information about the ReActiv8 study can be found here or by calling 248-794-1106.